Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MET | P08581 | 20/20 | 0.66 |
| ▸ | NQO2 | P16083 | 1/20 | 0.66 |
| ▸ | PDE4C | Q08493 | 2/20 | 0.47 |
| ▸ | PDE4D | Q08499 | 2/20 | 0.47 |
| ▸ | PDE3B | Q13370 | 2/20 | 0.47 |
| ▸ | PDE3A | Q14432 | 2/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30948875 | 0.90 | MET (0.70) | METNQO2PDE4CPDE4DPDE3B | |
| SCHEMBL22109176 | 0.90 | MET (0.70) | METNQO2PDE4CPDE4DPDE3B | |
| SCHEMBL22109378 | 0.83 | MET (0.67) | METNQO2PDE4CPDE4DPDE3B | |
| SCHEMBL22109376 | 0.81 | MET (0.65) | METNQO2PDE4CPDE4DPDE3B | |
| SCHEMBL22109153 | 0.81 | MET (0.72) | METNQO2PDE4CPDE4DPDE3B | |
| SCHEMBL30948870 | 0.80 | MET (0.65) | MET | |
| SCHEMBL22109396 | 0.80 | MET (0.65) | MET | |
| SCHEMBL20004072 | 0.80 | MET (0.78) | METNQO2PDE4CPDE4DPDE3B | |
| SCHEMBL21801854 | 0.80 | MET (0.78) | METNQO2PDE4CPDE4DPDE3B | |
| SCHEMBL30733000 | 0.80 | MET (0.78) | METNQO2PDE4CPDE4DPDE3B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3893872-B1 | ORGANOPHOSPHORUS-SUBSTITUTED COMPOUNDS AS C-MET INHIBITORS AND THERAPEUTIC USES THEREOF | BETA PHARMA INC (US) | 2024-07-17 | — | — | EP | disclosed |
| WO-2020124060-A1 | ORGANOPHOSPHORUS-SUBSTITUTED COMPOUNDS AS C-MET INHIBITORS AND THERAPEUTIC USES THEREOF | BETA PHARMA, INC. (US) | 2020-06-18 | — | — | WO | disclosed |